Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | Di-tert-butyl dicarbonate | HCID 90495 | — |
| Reactant | Sodium triacetoxyborohydride | HCID 5049666 | — |
| Reactant | HCID 70125262 | HCID 70125262 | — |
| Reactant | HCID 131722699 | HCID 131722699 | — |
| Reactant | HCID 178418361 | HCID 178418361 | — |
| Catalyst | Palladium | HCID 23938 | — |
| Solvent | Methanol | HCID 887 | — |
| Product | HCID 20664090 | HCID 20664090 | 37.5% |
Reaction Steps
A solution of 2-(R)-(3-(R)-Formyl-4-(S)-(3-fluorophenyl) pyrrolidin-1-yl)-4,4-dimethylpentanoic acid, benzyl ester (27 mg, 0.065 mmol, from Step B) in 2 mL methanol was stirred over 20 mg 10% Pd/C under 1 atm of hydrogen. After 1 h the mixture was filtered and concentrated. The crude material was dissolved in 2 mL DCE and 4-(4-Benzyl-1-ethyl-(1H-pyrazol-5-yl))-piperidine HCl (26 mg, 0.085 mmol, from EXAMPLE 8 Step F), triethylamine (21 μL, 0.15 mmol) and sodium triacetoxyborohydride (32 mg, 0.15 mmol) were added. The solution was stirred overnight then Boc anhydride (19 mg, 0.085 mmol) was added and stirring was continued for 3 h. The mixture was concentrated and the product was purified by flash chromatography (95/5 DCM/MeOH→95/5/0.5 DCM/MeOH/NH4OH) to afford 14 mg (37%) of the title compound. 1H NMR (500 MHz, CDCl3). δ1.03 (s, 9H), 1.31-1.34 (t, 3H), 1.36-1.45 (m, 1H), 1.5-1.59 (m, 1H), 1.64-1.72 (m, 2H), 1.76-1.8 (d, 1H), 1.91-2.0 (m, 2H), 2.08-2.13 (t, 1H), 2.37-2.4 (dd, 1H), 2.46-2.6 (m, 2H), 2.77-2.8 (m, 2HO, 2.96-3.0 (d, 1H), 3.18-3.37 (m, 2H), 3.56-3.6 (d, 1H), 3.7-3.82 (m, 2H), 3.85 (s, 2H), 4.01-4.05 (q, 2H), 5.72 (s, 1H), 6.97-7.0 (t, 1H), 7.13-7.2 (m, 5H), 7.22-7.28 (m, 2H), 7.33-7.4 (m, 1H). ESI-MS, M/z; (M+H)=575.6 (obs), 575.37 (calc.).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06248755B1 |
|---|
| Source dataset | uspto-grants-2001_06 |
|---|
| ORD ID | ord-f5480934dfca451ca553f21891d55301 |
|---|
| Source note | uspto-grants-2001_06 |
|---|